|
1
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO classification of tumours of the digestive system.
World Health Organization; 2010
|
|
2
|
Everhart JE and Ruhl CE: Burden of
digestive diseases in the United States part II: Lower
gastrointestinal diseases. Gastroenterology. 136:741–754. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang AG, Yoon SY, Oh JH, Jeon YJ, Kim M,
Kim JM, Byun SS, Yang JO, Kim JH, Kim DG, et al: Identification of
intrahepatic cholangiocarcinoma related genes by comparison with
normal liver tissues using expressed sequence tags. Biochem Biophys
Res Commun. 345:1022–1032. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Obama K, Ura K, Li M, Katagiri T, Tsunoda
T, Nomura A, Satoh S, Nakamura Y and Furukawa Y: Genome-wide
analysis of gene expression in human intrahepatic
cholangiocarcinoma. Hepatology. 41:1339–1348. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sia D, Losic B, Moeini A, Cabellos L, Hao
K, Revill K, Bonal D, Miltiadous O, Zhang Z, Hoshida Y, et al:
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion
and ARAF mutations in intrahepatic cholangiocarcinoma. Nat Commun.
6:60872015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim D, Pertea G, Trapnell C, Pimentel H,
Kelley R and Salzberg SL: TopHat2: Accurate alignment of
transcriptomes in the presence of insertions, deletions and gene
fusions. Genome Biology. 14:R362013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trapnell C, Roberts A, Goff L, Pertea G,
Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL and Pachter L:
Differential gene and transcript expression analysis of RNA-seq
experiments with TopHat and Cufflinks. Nat Protoc. 7:562–578. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ward JH Jr: Hierarchical grouping to
optimize an objective function. J Am Statist Assoc. 58:236–244.
1963. View Article : Google Scholar
|
|
9
|
Kanehisa M and Goto S: KEGG: Kyoto
encyclopedia of genes and genomes. Nucleic Acids Res. 28:27–30.
2000. View Article : Google Scholar
|
|
10
|
Patel T: New insights into the molecular
pathogenesis of intrahepatic cholangiocarcinoma. J Gastroenterol.
49:165–172. 2014. View Article : Google Scholar :
|
|
11
|
DeMorrow S, Francis H, Gaudio E, Venter J,
Franchitto A, Kopriva S, Onori P, Mancinelli R, Frampton G, Coufal
M and Mitchell B: The endocannabinoid anandamide inhibits
cholangiocarcinoma growth via activation of the noncanonical Wnt
signaling pathway. Am J Physiol Gastrointest Liver Physiol.
295:G1150–G1158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cunningham F, Amode MR, Barrell D, Beal K,
Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G,
Fitzgerald S, et al: Ensembl 2015. Nucleic Acids Res. 43(Database
issue): D662–D669. 2015. View Article : Google Scholar :
|
|
13
|
Wang S, Huang J, He J, Wang A, Xu S, Huang
SF and Xiao S: RPL41, a small ribosomal peptide deregulated in
tumors, is essential for mitosis and centrosome integrity.
Neoplasia. 12:284–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang A, Xu S, Zhang X, He J, Yan D, Yang Z
and Xiao S: Ribosomal protein RPL41 induces rapid degradation of
ATF4, a transcription factor critical for tumour cell survival in
stress. J Pathol. 225:285–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guijarro MV, Leal JF, Fominaya J, Lleonart
M, Castellvi J, Ruiz L, Ramon Y, Cajal S and Carnero A: MAP17
overexpression is a common characteristic of carcinomas.
Carcinogenesis. 28:1646–1652. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guijarro MV, Leal JF, Blanco-Aparicio C,
Alonso S, Fominaya J, Lleonart M, Castellvi J, Ramon y Cajal S and
Carnero A: MAP17 enhances the malignant behavior of tumor cells
through ROS increase. Carcinogenesis. 28:2096–2104. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guijarro MV, Link W, Rosado A, Leal JF and
Carnero A: MAP17 inhibits Myc-induced apoptosis through PI3K/AKT
pathway activation. Carcinogenesis. 28:2443–2450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sun Y, Du C, Wang B, Zhang Y, Liu X and
Ren G: Up-regulation of eEF1A2 promotes proliferation and inhibits
apoptosis in prostate cancer. Biochem Biophys Res Commun. 450:1–6.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu C, Hu DM and Zhu Q: eEF1A2 promotes
cell migration, invasion and metastasis in pancreatic cancer by
upregulating MMP-9 expression through Akt activation. Clin Exp
Metastasis. 30:933–944. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Browne GJ and Proud CG: Regulation of
peptide-chain elongation in mammalian cells. Eur J Biochem.
269:5360–5368. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tomlinson VA, Newbery HJ, Wray NR, Jackson
J, Larionov A, Miller WR, Dixon JM and Abbott CM: Translation
elongation factor eEF1A2 is a potential oncoprotein that is
overexpressed in two-thirds of breast tumours. BMC Cancer.
5:1132005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kulkarni G, Turbin DA, Amiri A, Jeganathan
S, Andrade-Navarro MA, Wu TD, Huntsman DG and Lee JM: Expression of
protein elongation factor eEF1A2 predicts favorable outcome in
breast cancer. Breast Cancer Res Treat. 102:31–41. 2007. View Article : Google Scholar
|
|
23
|
Pinke DE, Kalloger SE, Francetic T,
Huntsman DG and Lee JM: The prognostic significance of elongation
factor eEF1A2 in ovarian cancer. Gynecol Oncol. 108:561–8. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tan MG, Ooi LL, Aw SE and Hui KM: Cloning
and identification of hepatocellular carcinoma down-regulated
mitochondrial carrier protein, a novel liver-specific uncoupling
protein. J Biol Chem. 279:45235–45244. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shiiba M, Nomura H, Shinozuka K, Saito K,
Kouzu Y, Kasamatsu A, Sakamoto Y, Murano A, Ono K, Ogawara K, et
al: Down-regulated expression of SERPIN genes located on chromosome
18q21 in oral squamous cell carcinomas. Oncol Rep. 24:241–249.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yeh CN, Weng WH, Lenka G, Tsao LC, Chiang
KC, Pang ST, Chen TW, Jan YY and Chen MF: cDNA microarray profiling
of rat cholangiocarcinoma induced by thioacetamide. Mol Med Rep.
8:350–360. 2013.PubMed/NCBI
|
